X Prize Foundation

NEW YORK (GenomeWeb News) – The X Prize Foundation has decided to cancel the Archon Genomics X Prize, saying that the plummeting cost of sequencing a genome had rendered the competition moot.

The Archon Genomics X Prize, backed by a new sponsor, has revised the guidelines for the competition to reflect its interest in attaining a "medical grade genome," the X Prize Foundation said this week.

Earlier this month, the X Prize Foundation appointed Grant Campany as senior director for the Archon Genomics X Prize. The prize offers a $10 million cash award to the first team to sequence 100 human genomes in 10 days or less for a maximum of $1 million in total costs.

Cracker becomes the first Asia-based contender for the $10 million prize and eighth contender overall.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.